Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- Montefiore Medical Center
- Study ID
- NCT06510322
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Vascular Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sildenafil — DRUGOrally administered phosphodiesterase-5 (PDE-5) inhibitor, which enhances nitric oxide signaling in platelets and blood vessels.
- Placebo — OTHERMatched capsule not containing any medication
Study Details
Contemporary left ventricular assist device (LVAD) therapy improves survival during advanced heart failure but vascular aging develops rapidly leading to major adverse events including stroke and bleeding in nearly half of patients. In this study, the study team aims to investigate whether sildenafil pharmacotherapy, which has anti-fibrotic effects, can reduce vascular aging during LVAD support. An aim of this study is to compare changes in small blood vessels in the gastrointestinal tract between participants receiving sildenafil or placebo. Video capsule endoscopy (VCE) will be used to assess these changes in small blood vessels.
Key Dates
- Start date
- Mar 12, 2025
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: SildenafilParticipants in this arm will receive sildenafil 20mg every 8 hours for 1 week and then dose will be up titrated to 40mg every 8 hours for the duration of the study period.
- Placebo Comparator: PlaceboParticipants in this arm will receive matching placebo, which serves as a negative control to understand changes in small and large blood vessels.
Primary Outcome Measure
Change in Aortic Pulse Wave Velocity [ Time Frame: From Baseline to 180 days ]
Central Contacts
- Omar Saeed, MD718-920-2626
- Lorenzo D'Angelo, MD718-920-2626
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Montefiore Medical Center | The Bronx | New York | 10461 | - |
Find similar trials in The Bronx, NY
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Global Paradise System US Post Approval StudyRecruiting · ReCor Medical, Inc. · Sacramento, California
- A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)Recruiting · Fundación EPIC · Boston, Massachusetts
- Natural History of Stroke: Cause and DevelopmentRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Washington D.C., District of Columbia